Market Place
Sourcing Support
Plasma-Based Biomarker Could Predict Liver Fibrosis in Adolescents
17 Dec 2024 //
BUSINESSWIRE
n-Lorem Hosts Nano-Rare Colloquium With 750+ Attendees
12 Dec 2024 //
BUSINESSWIRE
n-Lorem Foundation Treats 15 Nano-rare Patients, More Expected
30 Oct 2024 //
BUSINESSWIRE
n-Lorem Shares Guide For Toxic Gain Mutation Treatment
03 Oct 2024 //
BUSINESSWIRE
n-Lorem Foundation Names Andrew W. Lo as a New Member of its Board of Directors
14 May 2024 //
BUSINESSWIRE
n-Lorem Foundation Welcomes New Member Alan Lotvin to Its Board of Directors
09 May 2024 //
BUSINESSWIRE
n-Lorem, Hongene Partner for Nano-Rare ASO Medicines
24 Apr 2024 //
BUSINESSWIRE
n-Lorem, Across Healthcare Platform For Nano-Rare Patients
16 Apr 2024 //
BUSINESSWIRE
n-Lorem Provides Update on Progress to Help Nano-rare Patients
19 Dec 2023 //
BUSINESSWIRE
n-Lorem Unveils Limited Edition Holiday Ornament to Provide ASO Therapies
28 Nov 2023 //
BUSINESSWIRE
Stanley Crooke, Named One of San Diego’s Most Influential People
22 Nov 2023 //
BUSINESSWIRE
n-Lorem Convenes Annual Nano-rare Patient Colloquium to Share Accomplishments
11 Oct 2023 //
BUSINESSWIRE
n-Lorem Foundation Collaborates to Support Children With Extremely Rare Diseases
04 Oct 2023 //
BUSINESSWIRE
n-Lorem Foundation CEO, Stanley Crooke Awarded the Steven C. Beering Award
08 Sep 2023 //
BUSINESSWIRE
n-Lorem Has Industrialized the Treatment of Nano-rare Patients
27 Jul 2023 //
BUSINESSWIRE
n-Lorem Foundation Welcomes Paul Compton and Neil Shneider to Board of Directors
02 Mar 2023 //
BUSINESSWIRE
n-Lorem Foundation Initiates Clinical Trials for Three Nano-rare Patients
19 Dec 2022 //
BUSINESSWIRE
n-Lorem Foundation CEO Publishes Important Perspective in Nucleic Acid Research
18 Jul 2022 //
BUSINESSWIRE
n-Lorem Foundation and Ultragenyx United in Efforts to Help Nano-rare Patients
20 Jun 2022 //
BUSINESSWIRE
n-Lorem Introduces First ‘Partner in Excellence’ in Nano-rare Patients
14 Jun 2022 //
BUSINESSWIRE
n-Lorem Launches its Patient Empowerment Program
25 May 2022 //
BUSINESSWIRE
Parexel and n-Lorem Foundation Partner for New Investigational Therapies
23 Feb 2022 //
BUSINESSWIRE
n-Lorem Foundation Partners with Argonaut to Manufacture ASO Medicines
02 Feb 2022 //
BUSINESSWIRE
n-Lorem Foundation Appoints Sarah Glass, Ph.D., as Chief Development Officer.
17 Aug 2021 //
BUSINESSWIRE
n-Lorem Foundation Announces Partnership with Nitto Avecia
16 Jun 2021 //
BUSINESSWIRE
n-Lorem Foundation Appoints Claire Grezemkovsky as Director of Philanthropy
07 Jun 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.